Implant Sciences device receives SAFETY Act designation

Implant Sciences Corporation announced on Thursday that its QS-B220 explosives and drugs trace detector received a SAFETY Act designation from the Department of Homeland Security.

The Support Anti-terrorism by Fostering Effective Technologies Act was enacted as part of the Homeland Security Act of 2002. The SAFETY Act encourages the development and use of anti-terrorism technology by creating liability protection. Claims because of, relating to or resulting from an "Act of Terrorism" where qualified anti-terrorism technologies were used have limited liability under the act.

The QS-B220 detects and identifies a wide range of explosives using ion-mobility spectrometry. Implant Sciences' QS-H150 handheld explosive trace detector also has a SAFETY Act designation.

"SAFETY Act designation is an important achievement, especially for our non-government customers," Implant Sciences President and CEO Glenn Bolduc said. "Coupled with our insurance coverage, the liability limitations built into the Act provide protection against lawsuits arising from the use of Implant Sciences' ETD equipment in defending against terrorism."

Implant Sciences is the first American-owned company to have product qualifications from the United States Transportation Security Administration, according to its website. The company has also received STAC certification from France and a Developmental Testing and Evaluation Designation from the United States Department of Homeland Security.